The widespread use of nonsteroidal anti-inflammatory drugs (NSAIDs) has led to their frequent detection in aquatic environments, raising serious concerns due to their persistence, toxicity, and potential to induce antibiotic resistance. Ibuprofen and diclofenac, which are produced at annual scales of approximately 15,000 and 940 metric tons, respectively, are often found in surface, ground, and even drinking water. Conventional wastewater treatments fail to eliminate these micropollutants completely and effectively, which necessitates advanced solutions. Among them, heterogeneous photocatalysis has emerged as a promising approach, although its application is limited by rapid electron‒hole recombination and partial mineralization. The addition of hydrogen peroxide (H2O2) has the potential to overcome these challenges by increasing reactive oxygen species generation and reducing charge recombination. Although previous reviews have explored photocatalysis and H2O2-based advanced oxidation processes (AOPs) for pharmaceutical degradation, their combined application for NSAIDs has received comparatively limited attention. This review analyzes recent progress in H2O2-assisted photocatalytic degradation of NSAIDs, emphasizing photocatalyst synthesis, H2O2 dosing, pH effects, and performance in real water matrices. It also examines the toxicity of transformation products and critical aspects, such as photocatalyst stability and reactor configurations. As water scarcity, climate change, and population growth intensify pressure on treatment systems, the development of adaptable and scalable technologies becomes urgent. Future directions, including in situ H2O2 production, real-time monitoring, and combined use with oxidants such as peroxymonosulfate, are highlighted as promising paths toward more efficient treatment. This work outlines a roadmap for advancing photocatalytic processes as viable tools for safeguarding water quality in diverse environmental scenarios.